Quentin M. Anstee

@QAnstee

Professor of Experimental Hepatology & Consultant Hepatologist: NAFLD/MASLD Treatment | Biomarkers | Pathogenesis | Genetics

Newcastle upon Tyne, UK ncl.ac.uk/medical-scienc… Joined June 2014

351 Following 1.5K Followers 672 Posts

Latest posts 5

Quentin M. Anstee @QAnstee Jun 21, 2023

‼️Grow your career as a Clinical Researcher 🔬🩺👨‍⚕️👩🏽‍⚕️
✅ Study #NAFLD #Cirrhosis outcomes & biomarkers in exciting project
✅ Clinical PhD fellowship in Newcastle Liver Group
@EASLedu @BritSocGastro #ILC2023 #BSGLIVE23 @NIHRNewcBRC #LiverTwitter pls RT

jobs.ncl.ac.uk/job/Clinical-R…

jobs.ncl.ac.uk Clinical Research Associate Clinical Research Associate

Quentin M. Anstee @QAnstee Jun 20, 2023

📣Calling all attendees @EASLnews #ILC2023!! Please spread the word 😊
➡️ Two great opportunities for enthusiastic scientists 👩‍🔬🧑‍🔬👨🏽‍🔬 to join the @UniofNewcastle Liver Research Group.
➡️ Exciting new project on #NASH #NAFLD #Cirrhosis 🔬🧪🧬

jobs.ncl.ac.uk/job/Research-A…

jobs.ncl.ac.uk Research Associate Research Associate

Quentin M. Anstee @QAnstee Apr 11, 2023

📣Delighted to see this paper from @LITMUS_IMI out in @NatMetabolism. Deep dive into protein-transcriptomic profile of progressive #NAFLD #NASH & new biomarkers. Congratulations and thanks to all collaborators in this major effort 💪 @UniofNewcastle @NCL_medresearch @NIHRNewcBRC

Nature Metabolism Verified account @NatMetabolism Apr 10, 2023

Online now! A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures dlvr.it/SmGQjz

View quoted post on X

Quentin M. Anstee @QAnstee Mar 30, 2023

Important data - congratulations @DrLoomba and colleagues 👏

Journal of Hepatology @JHepatology Mar 30, 2023

In people with type 2 diabetes:
➡️#NAFLD prevalence: 65%
➡️#Fibrosis prevalence: 14%
➡️#Cirrhosis prevalence: 6% (
➡️Obesity amplifies the risk of NAFLD and advanced fibrosis

Full text👉bit.ly/3UZrk1D

@DrLoomba
#LiverTwitter

View quoted post on X

Quentin M. Anstee @QAnstee Mar 21, 2023

🔥Hot paper from @LITMUS_IMI - results of the LITMUS Metacohort comparative analysis of 17 different biomarkers for #NAFLD #NASH published today in @LancetGastroHep. Thanks to all the team that have contributed to this work. thelancet.com/journals/langa…

www.thelancet.com Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver... None of the single markers or multimarker scores achieved the predefined acceptable AUC for replacing biopsy in detecting people with both NASH and clinically significant fibrosis. However, several...